Foxp3 + regulatory T cells (T reg cells) maintain immunological tolerance and their deficiency results in fatal multi-organ autoimmunity. Although heightened T cell receptor (TCR) signaling is critical for the differentiation of T reg cells, the role of TCR signaling in T reg cell function remains largely unknown. Here we demonstrate inducible ablation of the TCR results in T reg cell dysfunction which cannot be attributed to impaired Foxp3 expression, decreased expression of T reg cell signature genes or altered ability to sense and consume interleukin 2. Rather, TCR signaling was required for maintaining the expression of a limited subset of genes comprising 25% of the activated T reg cell transcriptional signature. Our results reveal a critical role for the TCR in T reg cell suppressor capacity.
repress at least some TCR-induced genes, as well as some genes involved in the TCR signaling pathway [5] [6] [7] [8] . At the same time, Foxp3 + T reg cells have high basal expression of several cell surface molecules which are known to contribute to T reg cell function (such as CD25, CD39 and CTLA-4) and whose expression in conventional CD4 + T cells is dependent upon TCR stimulation [9] [10] [11] [12] [13] [14] . Whether or not high affinity TCR interactions with self contribute to constitutive expression of these genes and consequently to T reg cell function is not known.
T reg cells-despite their intrinsically dampened response to TCR stimulation-acquire an activated phenotype and expand in response to their cognate antigens in settings of immune activation, such as infection and autoimmunity 15, 16 . These observations imply that selfantigen recognition helps maintain T reg cells of particular specificities and may potentiate their suppressive capacity during immune challenge 17 . Nevertheless, strict reliance on TCR expression for T reg cell activation-as opposed to preferential activation of antigen-specific T reg cells-has not been demonstrated, nor has TCR engagement in vivo been shown to be required for T reg cell function in any context.
We used inducible genetic ablation of cell surface TCR complexes to directly address the requirement of TCR expression for T reg cell immunosuppressive capacity. Notably, the TCR was largely dispensable for Foxp3 expression, lineage stability and for high expression of many T reg cell signature genes. Nevertheless, these features were not sufficient to preserve T reg cell function and to prevent immune activation. Loss of suppressor capacity in the absence of TCR was not due to impaired T reg cell ability to gain access to interleukin 2 (IL-2), and accordingly administration of exogenous IL-2 failed to rescue systemic autoimmunity. Instead, TCR expression was essential for T reg cell activation and maintenance of a limited set of genes which were found to be expressed almost exclusively in activated T reg cells. Among these genes, expression of the transcription factor IRF4 contributed to optimal T reg cell function and homeostasis. These results demonstrate an essential role for the TCR in eliciting the suppressor function of differentiated T reg cells.
Results

Maintenance of T reg cell identity in the absence of the TCR
In order to investigate the consequences of TCR signaling in T reg cell function, we crossed Foxp3 eGFP-CreERT2 mice to Cα FL mice to allow inducible deletion of Cα encoding the TCRα constant chain specifically in T reg cells 18, 19 . In this model, Cre-induced loss of the conditional Cα allele upon tamoxifen administration eliminates TCRα expression, preventing cell surface TCRαβ heterodimer formation. Tamoxifen was administered via oral gavage on days 0 and 1 and mice were analyzed on day 9. Allelic exclusion at the Cα locus in heterozygous Foxp3 CreERT2 Cα FL/WT mice yielded a minor population of TCR-deficient (TCR − ) T reg cells (~25%), while in homozygous Foxp3 CreERT2 Cα FL/FL mice the majority of T reg cells (~60-70%) lacked cell surface TCRβ (Fig. 1a) . Although we cannot definitively exclude the possibility that few residual TCR complexes were present in minute amounts (below the detection limit of flow cytometric analyses) on the TCR − T reg cells, functional in vitro analyses confirmed loss of TCR crosslinking-dependent activation of TCR − T reg cells ( Supplementary Fig. 1a-d ).
Because binding sites for the transcription factors NFAT and c-Rel have been identified within the Foxp3 locus, and TCR engagement-driven NF-κB signaling is critical for induction of Foxp3 expression, we speculated that the TCR might be essential to maintain Foxp3 expression [20] [21] [22] (Fig. 1b) . Similarly, the expression of several T reg cell signature molecules, including CD25, GITR, CD39 and CD73, was largely unaffected in TCR − T reg cells from both Foxp3 CreERT2 Cα FL/WT and Foxp3 CreERT2 Cα FL/FL mice ( Supplementary Fig. 1e ). These results indicates that, at steady state, continuous TCRmediated recognition of self does not contribute significantly to Foxp3-dependent maintenance of expression for these genes 11, 23 (Fig. 1c) 19 .
Requirement for the TCR in T reg cell effector differentiation
Although the T reg cell phenotype was largely preserved upon ablation of the TCR, we observed a relative enrichment of naïve-like CD44 lo CD62L hi cells among TCR − T reg cells in lymph nodes and spleens of Foxp3 CreERT2 Cα FL/WT and Foxp3 CreERT2 Cα FL/FL mice ( Fig.  2a and Supplementary Fig. 1g ). T reg cell proliferation is almost exclusively restricted to the CD44 hi subset, and in part, the enrichment we observed appeared to be a consequence of the severely impaired proliferative capacity of CD44 hi T reg cell in the absence of the TCR (Fig.  2b) 24 (Fig 2a,b and Supplementary Fig. 1h ). In Foxp3 CreERT2 Cα FL/FL mice, however, TCR − T reg cells exhibited considerable proliferative activity, albeit reduced in comparison to TCR + T reg cells present in the same mouse (Fig 2a) (Fig 2a, b) .
To address the possibility that continuous peripheral differentiation of naïve-like T reg cells into CD44 hi cells was impeded in the absence of TCR expression and that such a differentiation block contributed to the predominantly CD44 lo CD62L hi phenotype of TCR − T reg cells, we bred Cα FL mice to Foxp3 YFP-Cre mice to induce ablation of the TCR in newly generated, "naïve" T reg cells 25, 26 . We reasoned that if the TCR was critical for T reg cell effector differentiation in the periphery, TCR − T reg cells in these mice would retain a CD44 lo CD62L hi naïve-like phenotype. Supplementary Fig. 2c,d ).
Despite their generally intact T reg cell surface phenotype, nearly all TCR − T reg cells in healthy Foxp3 Cre Cα FL/WT mice had a naïve-like CD62L hi CD44 lo phenotype and lacked expression of all T reg cell differentiation markers tested, including KLRG1, CD103 and CXCR3 (Fig. 2c) . Notably, this pattern was also observed under severe inflammatory conditions in Foxp3 Cre Cα FL/FL mice, which were moribund by three weeks of age ( Fig. 2c and Supplementary Fig. 3e,f) Supplementary Fig. 2g,h ). Together, these data are consistent with an absolute requirement for TCR expression-loss of which cannot be compensated for even in conditions of extreme immune activation-for peripheral effector differentiation of naïve-like T reg cells and acquisition of an activated CD44 hi phenotype.
TCR-dependent effector function of mature Treg cells
Foxp3 expression and T reg cell expansion are facilitated by IL-2R signaling [27] [28] [29] (Fig. 3a,b) . Despite normal or even increased percentages of total Foxp3 + cells in the lymph nodes and spleens of Foxp3 CreERT2 Cα FL/FL mice, elevated numbers of CD4 + Foxp3 − and CD8 + T cell were found in the lymph nodes, and increased percentages of CD44 hi CD4 + and CD8 + T cells were found in the lymph nodes and spleens of these mice ( Fig. 3ca-d Immune activation in Foxp3 CreERT2 Cα FL/FL mice was milder than that resulting from complete T reg cell depletion in Foxp3 DTR mice, which express the human diphtheria toxin receptor (DTR) concomitantly with Foxp3 30 . Thus, it was possible that the large numbers of TCR − T reg cells in Foxp3 CreERT2 Cα FL/FL mice retained measurable TCR-independent suppressor capacity and were still capable of immune regulation. Alternatively, the minor population of remaining TCR-sufficient T reg cells in these mice might have limited the activation of effector T cells and the associated autoimmunity to some degree. To address these possibilities, we attempted to reduce the T reg cell percentages among CD4 + cells in Foxp3 DTR mice to approximate the percentages of the residual TCR-sufficient T reg cells in Foxp3 CreERT2 Cα FL/FL mice following four doses of tamoxifen 31 . We reasoned that if TCR − T reg cells were capable of significant suppression, autoimmunity in Foxp3 DTR mice subjected to only partial depletion of T reg cells would be more severe than in Foxp3 CreERT2 Cα FL/FL mice. As diphtheria toxin (DT) injection depletes T reg cells within 24 hours, while tamoxifen-induced Cre-ERT2 mediated recombination progressively increases over a four day period, we treated Foxp3 DTR , Foxp3 CreERT2 Cα WT/WT and Foxp3 CreERT2 Cα FL/FL mice each with DT four days after their first dose of tamoxifen (which like DT was administered to mice of all genotypes) in order to account for the time needed for complete Cre-ERT2-mediated deletion of Cα ( Supplementary Fig. 3a ,b and data not shown). Partial depletion of the T reg cell compartment in Foxp3 DTR mice resulted in CD4 + Foxp3 − T cell activation and cytokine production grossly comparable to that observed in Foxp3 CreERT2 Cα FL/FL mice harboring populations of TCR-sufficient T reg cells of a similar or even larger size (Supplementary Fig. 3b-d) . Together, these results demonstrate that T reg cells require continuous TCR expression for the effective elaboration of their suppressor function, and suggest that TCR − T reg cells, which are abundant in Foxp3 CreERT2 Cα FL/FL mice, are grossly devoid of detectable suppressor capacity.
TCR − T reg cell dysfunction is not secondary to impaired IL-2R signaling
We considered that the apparent loss of T reg cell suppressive capacity in the absence of the TCR might be an indirect consequence of an impaired ability to localize in a TCR-and antigen-dependent manner to sites of CD4 + T cell activation and to, thereby, acquire IL-2, a cytokine known to be critical for T reg cell function and homeostasis. This scenario would explain the decreased expression of Foxp3 and minimal proliferation of TCR − T reg cells in healthy Foxp3 CreERT2 Cα FL/WT mice, in which IL-2 amounts were not elevated and would not be able to partially remedy these defects 32 .
However, direct ex vivo analysis of phosphorylation of Stat5-which occurs downstream of IL-2 signaling in T reg cells-in spleen and lymph nodes showed at least equivalent proportions of p-Stat5 in TCR − and TCR + T reg cells in both Foxp3 CreERT2 Cα FL/WT and Foxp3 CreERT2 Cα FL/FL mice (Fig. 4a) . In Foxp3 CreERT2 Cα FL/FL mice, TCR − T reg cells had increased p-Stat5 compared to TCR + T reg cells, mirroring expression of CD25 and CD62L, which remained high on TCR − cells, but was decreased on the residual, activated TCR + T reg cells present in these mice ( Fig. 4a and Supplementary Figure 1e ,f). These results are consistent with the observation that p-Stat5 + T reg cells are largely found within the CD62L hi CD44 lo (and CD25 hi ) T reg cell subset which, in contrast to the activated CD44 hi CD62L lo (and CD25 int ) T reg cell subset, rely on IL-2R signaling rather than costimulatory receptor engagement for their maintenance 24 .
In vitro analysis confirmed that lack of TCR expression did not significantly influence Stat5 phosphorylation in response to IL-2, nor impair T reg cell ability to capture and deplete IL-2 from culture media, suggesting that in the absence of TCR expression T reg cell-mediated IL-2 deprivation may not be a significant mechanism of immune suppression ( Supplementary Fig. 4a,b) Fig. 4c,d ).
Lastly, administration of IL-2-anti-IL-2 complexes to Foxp3 CreERT2 Cα FL/FL mice did not diminish to any measurable extent the activation and lymphoproliferation of effector T cells caused by loss of TCR expression in T reg cells (Supplementary Fig. 5 ). Conversely, IL-2 depletion did not further exacerbate autoimmunity (data not shown). Notably, this was the case in spite of a 1.5-fold expansion of TCR − , but not TCR + , T reg cells following IL-2 administration (a likely consequence of higher CD25 expression and heightened IL-2 responsiveness by TCR − T reg cells) and a greater than two-fold reduction in TCR − T reg cells following IL-2 depletion (Fig. 4b and Supplementary Fig. 5b ). These observations further confirm that TCR − T reg cells-even when present in elevated numbers-possess minimal suppressive capacity. Together, these results indicate that neither TCR-dependent interactions with antigen presenting cells nor continuous TCR-mediated localization within lymphoid organs are required for T reg cell acquisition of IL-2, and that T reg cell dysfunction in the absence of TCR cannot be attributed to altered IL-2R signaling.
TCR expression promotes T reg cell adhesive properties in vitro
The in vitro suppressive capacity of T reg cells requires TCR engagement, possibly involving pathways independent of Zap70 catalytic activity-which is essential for conventional T cell effector function-but dependent on membrane proximal inside-out activation of integrins and subsequent enhancement of T reg cell interactions with antigen presenting cells 8 Fig. 6a ). As LFA-1 expression is higher on CD44 hi T reg cells in comparison to CD44 lo CD62L hi T reg cells, it is possible that superior conjugate formation by TCR + T reg cells, which are enriched for CD44 hi cells compared to TCR − T reg cells, may be due, at least in part, to increased expression of this integrin (Supplementary Figure 6b) . Although further work is necessary to determine precisely how TCR engagement in vivo affects signaling pathways to modulate T reg cell adhesive properties, our results indicate that TCR expression contributes to optimal T reg cell contact-dependent interactions with APCs, which may contribute to TCR-dependent immunosuppressive function.
TCR signaling modulates the effector T reg cell transcriptional signature
In order to explore whether TCR signals, apart from influencing T reg cell adhesion, might drive transcriptional events to license suppressor function in vivo, we conducted gene expression analysis of TCR + and TCR − T reg cells. Flow cytometric analysis showed that loss of TCR expression had a stronger effect on effector-like CD44 hi CD62L lo T reg cells compared to naïve-like CD44 lo CD62L hi T reg cells (data not shown) prompting us to investigate the gene expression profiles of these two populations separately within the TCR + and TCR − T reg cell populations isolated from healthy Foxp3 CreERT2 Cα FL/WT mice (to avoid confounding effects of immune activation). We found 155 genes were significantly downregulated, and only five genes were significantly up-regulated, by at least 2-fold in effectorlike CD44 hi CD62L lo TCR − T reg cells compared to CD44 hi CD62L lo TCR + T reg cells (Fig.  5a ). Sixteen genes were significantly down-regulated in the naïve-like CD44 lo CD62L hi TCR − T reg cells compared to CD44 lo CD62L hi TCR + T reg cells (all of them also downregulated in CD44 hi CD62L lo TCR − vs. TCR + T reg cells), whereas one gene was upregulated (Fig 5a) . 535 genes showed higher expression (2-fold or greater) in effector-like CD44 hi CD62L lo TCR + T reg cells compared to naïve-like CD44 lo CD62L hi TCR + T reg cells, and expression of 136 of them (25%) was TCR-dependent (Fig. 5b) . Importantly, 127 of the 155 genes (82%) down-regulated in the absence of TCR in CD44 hi CD62L lo T reg cells showed at least 2-fold higher expression in effector-like vs. naïve-like T reg cells.
Foxp3 has been proposed to solidify and amplify a transcriptional program initiated in T reg cell precursors by TCR engagement 9, 10, 35, 36 . We compared expression of the 155 genes identified above as being maintained by TCR in T reg cells (which we call TCR-dependent genes) to Foxp3-dependent genes, identified as upregulated in wild-type T reg cells compared to Foxp3 null -expressing T cells from Foxp3 GFPKO mice (which express a Foxp3 reporter null allele). 36 We found that a significantly enriched percentage of the TCR-dependent genes, compared to all genes, were also Foxp3-dependent (Fig. 5c ). These observation suggest that the TCR-driven transcriptional program in T reg cells is enhanced by Foxp3 expression, but that Foxp3 alone is not sufficient to maintain the full effector T reg cell transcriptional signature.
Examination of the TCR-dependent genes identified several transcription factors that were upregulated in TCR + compared to TCR − CD44 hi CD62L lo T reg cells as well as compared to TCR + and TCR − CD44 lo CD62L hi T reg cells, including NFATc1, c-Rel, Bcl6 and IRF4 the latter two of which were previously shown to be important for T reg cell effector differentiation and function (Fig 5d) . [37] [38] [39] Of the 155 TCR-dependent genes, we identified only one gene encoding an adhesion molecule, Vcam1, which was similarly upregulated in CD44 hi CD62L lo T reg cells compare to CD44 lo CD62L hi T reg cells in a manner than depended upon TCR expression (Fig. 5d) . Several genes encoding potential effector molecules were also found to be upregulated in CD44 hi CD62L lo vs. CD44 lo CD62L hi T reg cells in a TCRdependent manner, including IL-1R2, a decoy receptor for IL-1, and the immune inhibitory molecules CD83, CD200, and LAG-3, as well as IL-10 and EBI3, a subunit of the cytokines IL-27 and IL-35, all of which have been implicated in T reg cell function 26, [40] [41] [42] [43] [44] [45] . In addition, the chemokine-encoding genes Cxcl10 and Ccl1, as well as Ccr8 encoding the receptor for CCL1, were significantly down-regulated in TCR − compared to TCR + T reg cells, suggesting that T reg cells may signal each other through the expression of chemokines and their corresponding receptors, or may recruit into close proximity the targets of their suppressive acitivity 46 .
All together, these data indicate that, under physiologic conditions, a substantial portion of the effector-but not the naïve-like-T reg cell transcriptional program characterized by elevated expression of several potential T reg cell effector molecules, is maintained by continuous TCR signaling.
IRF4 expression promotes T reg cell function and homeostasis
To begin to assess the importance of the TCR-dependent transcriptional program for continuous T reg cell function in vivo, we focused on IRF4 as a downstream target of the TCR signaling pathway in T reg cells. We confirmed that elevated IRF4 expression in T reg cells was restricted to CD44 hi cells and was reduced to basal levels upon TCR ablation in both Foxp3 CreERT2 Cα FL/WT and Foxp3 CreERT2 Cα FL/FL mice ( Supplementary Fig. 7a ). Foxp3 YFP-Cre Irf4 FL/-mice, in which IRF4 is constitutively deleted in T reg cells, have been shown to develop a severe T H 2 cytokine-dominated autoimmunity by 8 weeks of age 37 Fig. 6a and Supplementary Fig. 7b . qPCR analysis indicated a ~50% reduction in Irf4 mRNA transcript amount in T reg cells sorted from pooled spleens and lymph nodes of tamoxifen-treated Foxp3 CreERT2 Irf4 FL/FL compared to Foxp3 CreERT2 Irf4 WT/WT mice (Fig. 6a) .
We hypothesized that the suboptimal ~50% reduction in mRNA amount and the only slight reduction in IRF4 protein expression in the spleens and lymph nodes of Foxp3 CreERT2 Irf4 FL/FL compared to Foxp3 CreERT2 Irf4 WT/WT mice might have resulted from a competitive disadvantage of T reg cells lacking IRF4 protein, which might lead to preferential expansion of IRF4-sufficient T reg cells remaining in Foxp3 CreERT2 Irf4 FL/FL mice. This would be consistent with the reported observation that the survival and expansion of strongly antigen-stimulated CD8 + T cells was greatly impaired in the absence of IRF4 48 . In order to assess whether IRF4 might similarly contribute to the maintenance of T reg cells that have been strongly activated, we looked in the colonic lamina propria, in which nearly all T reg cells were CD44 hi and likely had recently experienced TCR engagement based on robust IL-10 production (data not shown). Indeed, we observed decreased percentages of colonic lamina propria T reg cells in Foxp3 CreERT2 Irf4 FL/FL compared to Foxp3 CreERT2 Irf4 WT/WT mice, similar to the decrease in T reg cell percentages seen in the colonic lamina propria of Foxp3 CreERT2 Cα FL/FL compared to Foxp3 CreERT2 Cα WT/WT mice (Fig. 6b) . As opposed to spleen and lymph node T reg cells, and consistent with their decreased percentages, colonic lamina propria T reg cells in Foxp3 CreERT2 Irf4 FL/FL mice exhibited a substantial reduction in IRF4 protein expression compared to T reg cells in Foxp3 CreERT2 Irf4 WT/WT mice (Fig. 6b) . We hypothesized that the reportedly low influx of circulating T reg cells into the colonic lamina propria at steady state may have precluded IRF4-sufficient cells from becoming activated and repopulating to wild type percentages the T reg cell niche in this tissue 24 .
Despite the only modest decrease in IRF4 expression in T reg cells isolated from the spleens and lymph nodes of Foxp3 CreERT2 Irf4 FL/FL mice, we were able to detect a very mild, but statistically significant increase in the percentage of CD44 hi and Ki67 + lymph node Foxp3 − CD4 + T cells as well as increased IFN-γ, IL-4 and IL-13 production by splenic Foxp3 − CD4 + T cells, suggesting that IRF4 expression downstream of TCR signaling in T reg cells contributes to T reg cells suppressive function (Fig. 6c,d ). An increase in the production of T H 2 cytokines was consistent with the phenotype of mice with constitutive ablation of IRF4 in T reg cells, whereas the increased IFN-γ was likely a consequence of the substantial T H 1 bias in the C56B/L6 adult mice prior to induced Irf4 deletion 37 . As a control, we confirmed that in the absence of tamoxifen treatment, CD4 + Foxp3 − T cell expression of CD44, Ki67, IFN-γ, IL-4 and IL-13 in Foxp3 CreERT2 Irf4 FL/FL and Foxp3 CreERT2 Irf4 WT/WT mice were indistinguishable, as were T reg cell percentages in the colonic lamina propria (data not shown), suggesting that the modest differences we observed between Foxp3 CreERT2 Irf4 FL/FL and Foxp3 CreERT2 Irf4 WT/WT mice upon tamoxifen treatment were not a consequence of the Irf4 FL allele itself. Together, these data indicate that even partial loss of IRF4 expression downstream of TCR engagement in T reg cells interferes with optimal suppressive function of these cells.
Discussion
Despite major progress in understanding the molecular mechanisms of TCR engagementdriven differentiation of T reg cells, the role of the TCR in T reg cell function in vivo has remained unclear. Here, we demonstrate that TCR signaling in differentiated T reg cells is dispensable for the maintenance of Foxp3 expression and for expression of many T reg cell characteristic markers. Although the bulk of the T reg cell-specific gene signature was also preserved in the absence of TCR, suppressor function was critically dependent on the TCR.
Given that antigen-activated CD4 + Foxp3 − T cells in lymphoid organs are thought to produce IL-2 in a spatially restricted manner, we considered the possibility that T reg cells might analogously require their TCRs to correctly position themselves to gain preferential access to IL-2, which might elicit their suppressive function by stimulating IL-2R. However, our in vivo and in vitro data suggests that T reg cells acquire and likely effectively deplete IL-2 in a TCR-independent manner, and thus may instead rely predominantly on CCR7 expression to ensure sufficient IL-2 exposure, as recently proposed 24 .
Our observation that newly generated T reg cells in Foxp3 Cre Cα FL/WT and Foxp3 Cre Cα FL/FL mice remained naïve-like upon loss of TCR and did not populate non-lymphoid tissues suggests that effector differentiation and expansion are TCR-and likely antigen-dependent processes. This finding may help explain the observation that distinct T reg cell TCR repertoires are displayed by T reg cells populations found in distinct lymphoid organs and tissues in adult mice 49, 50 . Furthermore, the fact that inducible ablation of the TCR resulted in a far more pronounced change in gene expression in the effector-like vs. the naïve-like T reg cell subset suggests that continuous TCR signaling may be selectively driving the homeostasis and suppressor function of effector-like T reg cells. As inducible deletion of the TCR in differentiated T reg cells precipitated autoimmunity, our data may suggest that allor the bulk-of T reg cell suppressor function in vivo is mediated by the CD44 hi effector-like T reg cell subset.
We found that partial inducible ablation of Irf4, expressed downstream of TCR engagement in CD44 hi T reg cells, resulted in a very mild, but highly reproducible immune activation. Although this result suggests that IRF4 expression is important for TCR-dependent Treg cell function, given the suboptimal Irf4 deletion and modest immune activation, to what extent and how TCR-dependent IRF4 induction in T reg cells contributes to their ability to suppress spontaneous autoimmunity remains to be determined. IRF4 may predominantly function to control maintenance of highly activated T reg cells, which was particularly evident in the colonic lamina propria and which, when altered, may affect the ability of the T reg cell pool to suppress. Alternatively, IRF4 may play a more direct role in promoting T reg cell suppressive activity, perhaps by driving expression of certain T reg cell effector molecules. Although we observed decreased ICOS expression on colonic T reg cells lacking IRF4, the remaining IRF4-sufficient T reg cells present in lymphoid organs of Foxp3 CreERT2 Irf4 FL/FL mice complicate a more rigorous identification of IRF4 targets (data not shown).
It is important to note, however, that the fact that naïve-like T reg cells do not express IRF4 and are overwhelmingly unaffected by TCR deletion on a transcriptional level is not necessarily an indication that these cells are non-functional or that they are not experiencing TCR engagement. Indeed, several genes including Egr1, Egr2 and Nr4a1 were found to be down-regulated in this T reg cell subset in the absence of TCR.
Future experiments will be necessary to elucidate the contributions of other individual T reg cell TCR-dependent genes to maintenance of immune tolerance in the steady state, and to the restraint of immune responses directed against commensal microorganisms, food and environmental antigens and pathogens. In this regard, it is noteworthy that while IL-10 production by T reg cells has been implicated in the control of inflammatory responses at environmental interfaces such as the gut, lungs and skin, it has also been shown to be dispensable for T reg cell control over systemic autoimmunity 26 . Likewise, we found that while constitutive deletion of calcineurin B1 in Foxp3 Cre Cnb1 FL/FL mice (which eliminated calcineurin-dependent NFAT activation in T reg cells) resulted in lethal early onset autoimmunity, highly efficient inducible deletion in adult lymphoreplete Foxp3 CreERT2 Cnb1 FL/FL mice had no detectable adverse consequences on T reg cell function (data not shown). Together, these findings suggest that TCR engagement on T reg cells may drive a focused transcriptional program, select aspects of which are required in a context dependent manner for mediation of a broad range of T reg cell immunosuppressive functions.
Online Methods
Mice
Mice were bred and housed in the pathogen-free animal facility at Memorial SloanKettering Cancer Center and were used in accordance with institutional guidelines. Unless otherwise noted, 8-10 week old mice were used for all experiments. Foxp3 YFP-Cre , Foxp3 eGFP-CreERT2 , Rosa26 YFP , Foxp3 DTR , and Irf4 FL mice have been previously described 19, 26, 30, 47 . We thank Marc Schmidt-Supprian and Klaus Rajewsky for kindly providing Cα FL mice. For tamoxifen administration, 40mg tamoxifen were dissolved in 100ul ethanol and subsequently in 900uL olive oil (Sigma-Aldrich) and sonicated 4 × 30 seconds in a Bioruptor Twin (Diagenode). Mice were orally gavaged with 200 µl tamoxifen emulsion per treatment. For diphtheria toxin (DT) injections, DT was dissolved in PBS and 200 µl of indicated doses were injected i.p per mouse. For in vivo IL-2 depletion, mice were gavaged with tamoxifen on days 0 and 1 or on days 0, 3, 7 and 10 and injected i.p. on days 4 and 8 with a 0.5mg 1:1 mix of IL-2 neutralizing JES6-1A12 and S4B6-1 antibodies or IgG2a isotype (BioX-Cell). For administration of IL-2-anti-IL2 complexes, 1ug recombinant mouse IL-2 (R&D Systems) was incubated for 10 minutes at room temperature with 5 µg JES6-1 (BioXCell) and diluted to 200 µl in PBS immediately before i.p injection. Mice were gavaged with taxomofen on days 0, 3, 7 and 10 and received IL-2-anti-IL-2 complexes or PBS on days 5, 7, 9 and 11.
FACS staining and cell isolation
Cells were stained with LIVE/DEAD Fixable Yellow Dead Cell Stain (Molecular Probes) and antibodies listed in Supplementary Table 1 . For BrdU experiments, mice were injected i.p. with 1mg BrdU in 1mL PBS and staining was performed using the BD Pharmingen BrdU Flow Kit. Flow cytometric analysis was performed using an LSRII flow cytometer (BD Bioscience) and FlowJo software (Tree Star). For cell isolation, CD4 + T cells were purified from pooled spleen and lymph node cell suspensions using magnetic Dynabeads (Invitrogen) and further sorted using an Aria II cell sorter (BD Bioscience). Intracellular staining was performed using eBioscience Fixation Permeabilization buffers. For cytokine staining lymph node and spleen cells were stimulated with soluble anti-CD3 clone 2C11 (5ug/ml) and anti-CD28 clone 37.51 (5ug/ml) in the presence of 1ug/mL brefeldin A for 4-6 hours at 37°C, 5% CO 2 .
In vitro proliferation assay
Dendritic cells (DCs) were expanded in vivo by subcutaneous injection of B16 melanoma cells secreting Flt3 ligand into the left hind flank of B6 mice. Once tumors were visible, spleens from injected animals were dissociated in RPMI 1640 medium containing 1.67 units/mL liberase TL (Roche) and 50 µg/mL DNAse I (Roche) for 20 min at 37 °C with shaking. EDTA was added at a final concentration of 5 mM to stop digestion and the resulting homogenate was processed for CD11c + cell isolation using the MACS mouse CD11c (N418) purification kit (Miltenyi Biotec). FACS purified CD4 + eGFP + cells from tamoxifen treated Foxp3 CreERT2 Cα FL/WT mice were labeled with CellTrace Violet (Molecular Probes) according to the manufacturer's instructions and plated in triplicate in 96-well flat bottom plates (5 × 10 4 cells/well) in media containing 25 U/mL human recombinant IL-2 (PeproTech) with or without equal numbers of DCs, with or without 100ng/mL LPS (E. coli 0111:B4, Sigma-Aldrich.)
In vitro IL-2 stimulation and pSTAT5 detection
Foxp3 CreERT2 Cα FL/WT mice were treated with tamoxifen on days 0 and 1, and on day 9 CD4 + T cells were purified from pooled spleen and lymph node cell suspensions using magnetic Dynabeads (Invitrogen). Cells were stained with anti-CD4 and anti-TCRβ, washed, and plated in 96-well V-bottom plates (1 × 10 6 cells/well) in RPMI containing 10% FBS with or without increasing concentrations of IL-2 for 20 minutes at 37oC. Cells were subsequently processed using BD Phosflow Lyse/Fix Buffer and Perm Buffer III (BD Biosciences) and stained with anti-p-STAT5 Y694 antibody according to the manufacturer's instructions. T reg cells were identified by eGFP expression. For ex vivo p-STAT5 staining, spleen and lymph nodes were dissociated at 4°C in PBS (0.5% BSA) containing anti-CD4 and anti-TCRβ antibodies, stained for 10 minutes on ice, and washed twice before fixation.
In vitro IL-2 depletion
Foxp3 CreERT2 Cα FL/WT mice were treated with tamoxifen on days 0 and 1, and on day 9 pooled spleens and lymph nodes were enriched for CD4 + cells and subsequently sorted to >99% purity into eGFP + TCRβ + , eGFP + TCRβ − , and eGFP − TCRβ + populations. Each population was divided among 8 wells of a V-bottom 96-well plate (250,000 cells/well) in 25uL RPMI(10%) with or without increasing doses of recombinant human IL-2 for 2 hours at 37°C. IL-2 depletion from the media was assessed using the BD Cytometric Bead Array and Human IL-2 Enhanced Sensitivity Flex Set (BD Biosciences) according to the manufacturer's instructions. represent an aggregate of three independent experiments with a total of six or more mice per group. **, P < 0.001; *, P < 0.01. P-values were calculated using an unpaired t-test. following tamoxifen treatment on days 0, 3, 7 and 10 and i.p. injections of IL-2 neutralizing or isotype antibody on days 4 and 8. The data in (b) is representative of two experiments with two or more mice per group each. ***, P < 0.001; **, P < 0.01; *, P < 0.05. P-values were calculated using an unpaired t-test. 
In vitro conjugation assay
